Naprosyn and Epicondylitis - a phase IV clinical study of FDA data

Summary:

Epicondylitis is reported as a side effect among people who take Naprosyn (naproxen), especially for people who are female, 50-59 old, have been taking the drug for 10+ years also take Ambien, and have Osteoarthritis.

The phase IV clinical study analyzes which people have Epicondylitis when taking Naprosyn. It is created by eHealthMe based on reports of 16,337 people who have side effects when taking Naprosyn from the FDA, and is updated regularly.

What is Naprosyn?

Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.

What is Epicondylitis?

Epicondylitis (tennis elbow) is found to be associated with 397 drugs and 427 conditions by eHealthMe. Check the latest studies of Epicondylitis.

On Aug, 01, 2026

16,337 people reported to have side effects when taking Naprosyn.
Among them, 27 people (0.17%) have Epicondylitis.

Among these 27 people:

How long have people been on Naprosyn when they have Epicondylitis? *

What is the gender of people who have Epicondylitis when taking Naprosyn? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Epicondylitis when taking Naprosyn? *

What are other drugs people take besides Naprosyn? *

What are other side effects people have besides Epicondylitis? *

Joint Pain: 16 people, 59.26%
Pain In Extremity: 15 people, 55.56%
High Blood Pressure: 13 people, 48.15%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 44.44%
Mitral Valve Incompetence (inefficient heart valve): 12 people, 44.44%
Sacroiliitis (an inflammation of the sacroiliac joint): 11 people, 40.74%
Upper Respiratory Tract Infection: 11 people, 40.74%
Headache (pain in head): 11 people, 40.74%
Arthropathy: 11 people, 40.74%
Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 10 people, 37.04%

What are the existing conditions these people have? *

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 18.52%
Insomnia (sleeplessness): 4 people, 14.81%
Folliculitis (infection of hair root): 4 people, 14.81%
Depression: 2 people, 7.41%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 7.41%
Upper Respiratory Tract Infection: 1 person, 3.70%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 3.70%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 3.70%
Diarrhea: 1 person, 3.70%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Naprosyn and have Epicondylitis?

- Check whether Epicondylitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Naprosyn:

Naprosyn (16,738 reports)

Epicondylitis treatments and more:

Epicondylitis (2,870 reports)

Browse all side effects of Naprosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epicondylitis:

Epicondylitis (397 drugs)

Browse all the conditions that are associated with Epicondylitis:

Epicondylitis (427 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on naproxen (the active ingredients of Naprosyn) and Naprosyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.